
FARXIGA for CKD | Heart Failure | Type 2 Diabetes
FARXIGA® (dapagliflozin), a medication for people with chronic kidney disease (CKD), heart failure with symptoms, and type 2 diabetes.
FARXIGA
For adults with type 2 diabetes, FARXIGA reduces the risk of hospitalization for heart failure in those with heart disease or risk factors for it. FARXIGA also improves blood sugar control in adults and …
FAQs | FARXIGA® (dapagliflozin)
The most common side effects of FARXIGA include yeast infections of the vagina or penis, and changes in urination, including urgent need to urinate more often, in larger amounts, or at night.
Possible Side Effects of FARXIGA® (dapagliflozin)
The most common side effects of FARXIGA include yeast infections of the vagina or penis, and changes in urination, including urgent need to urinate more often, in larger amounts, or at night.
StartSmart | FARXIGA® (dapagliflozin)
Learn how FARXIGA® (dapagliflozin) can help adults with CKD or HF. Discover resources, tips and support to get started on right path.
FARXIGA
For adults with chronic kidney disease (CKD), FARXIGA is a prescription medicine approved to reduce the risk of further worsening of kidney disease, end-stage kidney disease, death due to …
Understanding heart failure, and what you can do - FARXIGA
The most common side effects of FARXIGA include yeast infections of the vagina or penis, and changes in urination, including urgent need to urinate more often, in larger amounts, or at night.
Usos aprobados para FARXIGA® (dapagliflozin) ¿Qué es FARXIGA? FARXIGA es un medicamento con receta que se utiliza: • Para reducir el riesgo de mayor empeoramiento de su enfermedad renal, …
EGFR Kidney Numbers | FARXIGA® (dapagliflozin)
FARXIGA is not for use to improve blood sugar (glucose) control in people with type 2 diabetes who have moderate to severe kidney problems, because it may not work.
For adults with chronic kidney disease (CKD), FARXIGA® (dapagliflozin) is a prescription medicine approved to reduce the risk of further worsening of kidney disease, end-stage kidney disease, death …